[ad_1]
According to SAM, for the drugs listed in the table, 10 pharmaceutical companies (Teva, Mylan Healthcare, GlaxoSmithkline, Sanofi, Pfizer, Novartis, Astra Zeneca, Novonordisk, Sandoz, Berlin Chemie) did not want to reduce the prices of 47 drugs, although they offer prices much lower for similar drugs in Europe. therefore, Lithuanian doctors miss the opportunity to prescribe these drugs to patients.
As announced this week, for this reason, doctors will not be able to prescribe up to 47 drugs to new patients starting in October, and will only be able to extend them to people who continue treatment. For new patients, doctors will be able to offer analog drugs that are just as effective.
| Medication name | 2020 Fourth Quarter Pricing Decisions | 2020 I pusm. number of patients | 2020 I pusm. Budgetary expenditure PSDF, Eur | Vine. referee. country price, Eur | Lithuania, applicable price, Eur | The difference | Proc. The difference |
| Medications 1 | as of October 1, reimbursed to continue treatment | 176 | 4,864 | 0.46 | 4.06 | 3.6 | 783 |
| Medicine 2 | as of October 1, reimbursed to continue treatment | 340 | 18,530 | 0.82 | 6.58 | 5.76 | 702 |
| Medicine 3 | as of October 1, reimbursed to continue treatment | 243 | 27,714 | 3.77 | 28.8 | 25.03 | 664 |
| Medicine 4 | as of October 1, reimbursed to continue treatment | 77 | 1,164 | 0.37 | 1.73 | 1.36 | 368 |
| Medicine 5 | as of October 1, reimbursed to continue treatment | 29 | 984 | 1.42 | 6.46 | 5.04 | 355 |
| Medicine 6 | as of October 1, reimbursed to continue treatment | 577 | 13,281 | 0.83 | 3.21 | 2.38 | 287 |
| Medicine 7 | as of October 1, reimbursed to continue treatment | 19 | 356 | 1.51 | 5.83 | 4.32 | 286 |
| Medicine 8 | as of October 1, reimbursed to continue treatment | 406 | 7,556 | 0.64 | 2.47 | 1.83 | 286 |
| Medicine 9 | as of October 1, reimbursed to continue treatment | 4 | Four. Five | 3.57 | 12.49 | 8.92 | 250 |
| Medication 10 | as of October 1, reimbursed to continue treatment | 52 | 19,425 | 19 | 57.23 | 38.23 | 201 |
This week, Health Minister Aurelijus Veryga officially addressed the representative offices of pharmaceutical companies in Lithuania and their headquarters, requesting before October 8. Reduce the prices of medicines so that they are similar to the prices of medicines offered in other European countries. Meanwhile, the State Health Insurance Fund (VLK) has been instructed to organize negotiations with these companies as a matter of urgency.
Ramūnas Karbauskis, the leader of the ruling, said in the Seimas on Thursday that ten international pharmaceutical companies applied special prices – electoral – to Lithuania to discredit the government and Health Minister Aurelijus Verygas. Pharmacists’ representatives reject such allegations, explaining that the room for political innuendo stems from faulty drug pricing principles.
According to SAM, active substances are not excluded from the price list, which VLK updates four times a year. This means they can be re-prescribed to new patients at any time, as long as the manufacturers cut prices.
[ad_2]
